Profilo
Rob Henderson worked as the Director of Product Management at Corixa Corp.
He then served as the Chief Scientific Officer at Viridian Therapeutics, Inc. from 2021 to 2024.
Dr. Henderson obtained his undergraduate degree from the University of Virginia.
Precedenti posizioni note di Rob Henderson
| Società | Posizione | Fine |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2024 |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | - |
Formazione di Rob Henderson
| University of Virginia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
- Borsa valori
- Insiders
- Rob Henderson
